Novel compression device to prevent hematomas after cardiovascular implantable electronic device implantation in patients receiving direct oral anticoagulants

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049430

Enrollment

Unknown

Registered

2021-08-02

Start date

2021-07-28

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sick sinoatrial node syndrome

Interventions

Experimental group:Using a new pacemaker hemostatic compression device

Control Group:traditional sandbag press

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged > 18 years old; 2. Patients after permanent pacemaker implantation. The age of the two groups of cases; 3. Gender, disease, drug treatment, etc. are all comparable.

Exclusion criteria

Exclusion criteria: Refused to participate in the study.

Design outcomes

Primary

Measure	Time frame
Incidence of hematoma;	—

Secondary

Measure	Time frame
patient comfort;	—

Countries

China

Contacts

Public ContactHe Chaojie

The First Hospital of Jiaxing

hechaojie824@163.com+86 18858370824

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026